Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
February 4, 2008

Karo Bio and Zydus Cadila Enter Inflammatory Disease Partnership

  • Karo Bio and Zydus Cadila are working together to discover and develop selective glucocorticoid receptor modulators for the treatment of inflammatory diseases.

    Under the three-year research collaboration Karo Bio will utilize its expertise in nuclear receptor drug discovery including structural biology, drug design, and compound characterization. Zydus Cadila will initiate a focused drug discovery and development program, undertaking preclinical studies, IND application filing, and clinical trials.

    Both parties will equally share the costs and and rewards from this partnership.

  • You’re all set! Thank you for subscribing to GEN Highlights.